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Abstract: The largest wastewater treatment plant in Jordan was monitored in the summer to determine the
removal of pharmaceuticals and personal care products (PPCPs). Grab samples were collected from the influent
and effluent of As-Samra Wastewater Treatment Plant (WWTP). Liquid chromatography and tandem mass
spectrometry (LC–MS/MS) were utilized to determine the concentrations of 18 compounds of pharmaceuticals
and personal care products (PPCPs). The results showed that 14 compounds were detected in the collected
samples from the influent and effluent of As-Samra WWTP. These compounds are 1,7-dimethylxanthine,
amphetamine, acetaminophen, caffeine, carbamazepine, cimetidine, cotinine, diphenhydramine,
methylenedioxymethamphetamine (MDMA), morphine, phenazone, sulfamethazine, sulfamethoxazole,
thiabendazole, and trimethoprim. However, four compounds were below the detection limit (<0.005 µg/L),
namely cimetidine, methylenedioxyamphetamine (MDA), methamphetamine, and sulfachloropyridazine.
Among PPCPs, the highest estimated average concentrations in raw wastewater were caffeine, acetaminophen,
1,7-dimethylxanthine, cotinine, and carbamazepine sampled during the summer, at an estimated concentration
of 155.6 µg/L, 36.7 µg/L, 10.49 µg/L, and 1.104 µg/L, respectively. However, the highest estimated average
concentrations in treated wastewater were for carbamazepine, sulfamethoxazole, caffeine, cotinine, and
acetaminophen, at 0.856 µg/L, 0.096 µg/L, 0.086 µg/L, 0.078 µg/L, and 0.041 µg/L, respectively. In general, the
results showed that some compounds in the collected samples of wastewater in Jordan have concentrations
exceeding the values reported in the literature. The removal efficiency rates of 1,7-dimethylxanthine,
acetaminophen, caffeine, cotinine, morphine, and trimethoprim were higher than 95%, while those of
carbamazepine, sulfamethazine, and sulfamethoxazole were lower than 22.5%. Moreover, diphenhydramine
and thiabendazole had negative removal efficiency rates. The removal efficiency rates of the PPCPs in As-Samra
WWTP were generally consistent with those of indicator compounds reported in the literature for conventional
WWTPs.

Keywords: pharmaceutical compounds; personal care products; wastewater treatment; activated
sludge system; removal efficiency

1. Introduction
The main sources of emerging contaminants are pharmaceuticals and personal care products
(PPCPs), endocrine disrupting chemicals (EDCs), plasticisers (e.g., bisphenol-A), flame-retardants,
fuel additives, and other industrial organic products [1]. PPCPs have been detected in all
environmental compartments, such as water, soil, air, biota, and wastewater at concentrations
ranging from sub-ng/L levels to µg/L [2,3]. The presence of these compounds in the environment has
been shown to result in adverse ecological and health risks for the exposed biota and humans, even
at very low concentrations (ng/L range) [4–6]. However, the literature indicates that the currently
Water 2019, 11, 2004; doi:10.3390/w11102004

www.mdpi.com/journal/water

Water 2019, 11, 2004

2 of 13

employed conventional wastewater treatment processes (primary and secondary) cannot not
effectively eliminate all PPCPs in the raw wastewater [7–11]. Therefore, municipal wastewater
treatment plants (WWTPs) are considered as a main source for the discharge of PPCPs into surface
waters.
With an increase in the contamination of waterways and water supply systems from these
pollutants and the greater reliance on alternative water sources such as reuse of treated wastewater,
it has become apparent that there is a need for further monitoring and research on the impact of
PPCPs on the environment. Recent studies conducted in Europe, USA, and Canada have showed that
the reuse of wastewater effluents (treated and untreated) can result in contamination of ground and
surface water resources by PPCPs [5,12,13]. However, the research efforts made to address this issue
in low-income countries (i.e., Jordan) are still lagging behind those in developed countries due to lack
of monitoring of PPCP compounds in water resources as well as lack of availability of the analytical
instruments and methods needed to identify PPCPs at low concentration levels (ng/L).
Jordan is currently relying on treated wastewater as one of the main water sources for
agricultural activities. About 95% of wastewater is treated, and more than 92% of treated wastewater
is reused in agricultural activities, which is one of the highest percentages of reuse among the Arab
countries [14]. According to a report published in 2018, there were 32 sewage WWTPs located in
Jordanian cities. The estimated amount of treated wastewater discharged by these plants is about 166
× 106 m3 [15]. As-Samra Wastewater Treatment Plant (WWTP) is considered the largest wastewater
treatment facility in Jordan. It is currently serving the governorates of Amman and Zarqa, where a
population of over 4 million people is growing rapidly. The plant treats annually more than 118 × 106
m3 wastewater released from the Zarqa River basin and drains most of its effluent into the King Talal
Dam, which provides irrigation water for most agricultural activities at Jordan Valley. The problem
of emerging contaminants has not received enough attention in Jordan. There are limited studies
examining the presence of PPCPs in the influent (raw wastewater) and effluent, and their removal
from As-Samra WWTP. Therefore, as far as we know, this is the first study to cover this issue in
Jordan.
The objective of this study was to evaluate the occurrence of PPCPs in the largest wastewater
treatment plant in Jordan (As-Samra WWTP, serving the cities of Amman and Zarqa) and to
determine the removal efficiency rates of the tested compounds during the summer season.
2. Materials and Methods
2.1. As-Samra WWTP
As-Samra Wastewater Treatment Plant (WWTP) is considered the largest wastewater treatment
facility in Amman Zarqa Basin in Jordan. The location of the plant is shown in Figure 1.
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Figure 1. Location of As-Samra Wastewater Treatment Plant (WWTP).

As-Samra WWTP was established in 1986 to treat wastewater generated from Amman and Zarqa
cities using wastewater stabilization ponds (WSPs). The WSPs were replaced by a new plant using
an activated sludge/extended aeration system and was designed to treat an average flow of 365,000
m3 per day in 2015. The treated wastewater from As-Samra WWTP is discharged to the King Talal
Dam. A schematic of the As-Samra WWTP is shown in Figure 2. The selected train included primary
sedimentation, secondary activated sludge, nitrifying treatment units and disinfection by
chlorination.
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Figure 2. Process flow schematic of As-Samra WWTP and sampling points.

2.2. Chemicals
Reference materials, metabolites, and labeled standards were obtained from Sigma–Aldrich (St.
Louis, MO, USA). The solvents used in sample preparation were of high-purity grade (OPTIMA,
Fisher Scientific, St. Louis, MO, USA).
2.3. Sample Collection, Preparation, and Extractions
Four grab samples were collected from the influent and effluent of As-Samra WWTP in 1-L glass
bottles rinsed with methanol and then washed with type I purified reagent water. All samples were
stored in a refrigerator under dark conditions at 4 to 8 °C. The extraction process was implemented
according to the procedure provided by Water Sciences Laboratory at the University of Nebraska–
Lincoln (WSL/UNL) in the United States (USA) [16]. Samples were pre-concentrated using solid
phase extraction (SPE) directly or within 24 h after collection. The collected samples were firstly
decanted to remove suspended particles and then filtered through 0.45-micron glass fiber filters using
a vacuum filtration unit. A polymeric Hydrophilic-Lipophilic Balanced (HLB) Oasis 6CC cartridge
(#WAT106202,200mg) from Waters Corporation (Milford, MA, USA) was connected to a SPE
manifold and vacuum pump and was preconditioned by passing 6 mL acetone and 6 mL methanol
sequentially through the cartridge, followed by 6 mL distilled deionized water (DDI H2O). The
filtered sample was then pumped via tube to the cartridge using a vacuum manifold system. The
sample flow through the SPE cartridge was kept at approximately 10 mL/min or less. After the whole
sample was extracted, the cartridge was rinsed with 5 mL of DDI H2O. Room air was allowed to flow
through the cartridge by continued suction for a minimum of 5 minutes to help dry the cartridge. All
cartridges were labeled with the necessary information and separately stored in a clean bag at −20 °C.
It is important to mention that the total number of collected samples (4) is relatively small compared
with similar studies reported in the literature, which is considered a limitation in this study.
2.4. Analytical Methods
Sample cartridges were eluted and analyzed using liquid chromatography tandem mass
spectrometry (LC-MS/MS). Cartridges were eluted with 3 mL of high-purity methanol into a
disposable glass culture tube, followed by addition of internal standards and surrogates. The eluant
volume was then reduced under a stream of nitrogen at 40 °C to a volume of 80 uL, and mixed with
320 µL of ammonium formate added to bring the sample volume to 400 µL, vortexed, and then
transferred to autosampler vials with silane-treated inserts. Eighteen PPCPs were measured, and
their physical and chemical properties, including pKa, Log of the octanol/water partition coefficient
(Log Kow), water solubility, and molecular weight are shown in Table 1. Sample processing and
instrumentation are similar to previously published methods [16–19].
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Table 1. Classification and physical and chemical properties of target pharmaceuticals and personal
care products.

Family and
Use

pKa

Log
Kow

Water
Solubility
mg/L

Molecular
Weight
g/mol

Stimulant

9.9

−0.78

1000

180.2

Analgesic

9.38

0.46

14,000

151.2

Amphetamine a

Stimulant

10.1

1.76

28000

135.2

Caffeine a

Stimulant

10.4

−0.07

21,600

194.2

Carbamazepine
a

Anticonvulsan
t

13.9

2.45

17.7

236.3

Cimetidine a

Antiacid

6.8

0.40

9380

252.3

Cotinine a

Stimulant

4.79

0.07

1,000,000

176.2

Diphenhydrami
ne a

Antihistamine

8.98

3.27

3060

255.4

Abuse drug

9.67

1.64

22,500

179.2

Methylenedioxy
methamphetamin
e (MDMA) a

Abuse drug

9.9

2.15

7034

193.3

Methamphetami
ne a

Stimulant

9.87

2.07

13,290

149.2

Morphine a

Narcotic
analgesic

8.21

0.89

149

285.3

Phenazone a

Analgesic

1.4

0.38

51,900

188.2

Sulfachloropyra
dazine b

Antibacterial

5.7

0.31

8235

284.7

Compound

1,7dimethylxanthi
ne a
Acetaminophen
a

Methylenedioxy
amphetamine

Chemical structure

(MDA) a
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Sulfamethazine

Antibacterial

7.45

0.8

1500

278.3

Sulfamethoxazo
le b

Antibiotic

6.1

0.48

3942

253.3

Thiabendazole b

Fungicide and
parasiticide

4.64

2.47

50

201.2

Trimethoprim a

Antibiotic

7.12

0.91

400

290.3

b

a

https://pubchem.ncbi.nlm.nih.gov/ [20] ; b Díaz-Cruz et al. [21].

Compound separation was achieved on an Agilent Series 1100 HPLC system (Santa Clara, CA,
USA) equipped with a Thermo-Scientific C18 embedded column (250 mm × 2.1 mm, particle size 5
µm). The gradient method was used with 0.5 g/L ammonium formate in water as eluent A and 0.5
g/L ammonium formate in methanol as eluent B in gradient elution mode at a flow rate of 0.2 mL/min.
Initial mobile phase conditions were 100:0 A/B for 1 min followed by a linear gradient to attain a
composition of 60:40 A/B at 10 min, then changing to another linear gradient to reach a composition
of 5:95 A/B at 18 min. The final composition was held for 10 min before returning to the initial
conditions. The injection volume was 20 µL.
Multiple reaction monitoring (MRM) was carried out on an Agilent 6410 triple-quadrupole mass
spectrometer equipped with an electrospray ionization interface, using the positive-ion mode (Santa
Clara, CA, USA). The conditions for the analysis were as follows: drying gas temperature, 350 °C;
capillary voltage, 4.0 kV; drying gas flow, 12 L/min; and nebulizer pressure, 40 psi. The Agilent
MassHunter software was used for instrument control, data acquisition, and quantitation (Santa
Clara, CA, USA).
Method detection limits were determined from the standard deviation of replicate extraction
and analysis of 8 low-level (0.015 µg/L) fortified blanks and ranged from 0.002 to 0.050 µg/L with
recoveries ranging from 65% to 185%. Quality controls processed with cartridges included laboratory
reagent blanks and laboratory fortified blanks included at a rate of 5%. Surrogate recoveries ranged
from 27% to 127% in sample extracts.
3. Results
3.1. Operating Conditions of As-Samra WWTP
The operating conditions were obtained from the plant and are summarized in Table 2. AsSamra WWTP has three parallel treatment trains.
Table 2. Wastewater quality and operating conditions for the influent and effluent in As-Samra
WWTP during sample collection.

Sampling
Date
17 June
2017
6 July
2017

Flow
Rate
(m3/day)
322246
336045

Sampling
Point

pH

Influent
Effluent
Influent
Effluent

7.29
7.02
7.11
7.10

Chemical
Oxygen
Demand
(COD),
(mg/L)
517
127
1183
44.5

Biological
Oxygen
Demand
(BOD5),
(mg/L)
620
8
540
5

Total
Suspended
Solids
(TSS),
(mg/L)
480
18.0
501
10.0

Total
Nitrogen
(T-N),
(mg/L)

Total
Phosphorus
(T-P),
(mg/L)

96
12.2
98
14.4

11.4
2.2
11.3
6.5
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The water samples for this study were collected after the grit removal unit (influent) and prior
to disinfection (effluent). The average flow of As-Samra WWTP was 323,790 m3/day during the
sampling time. Moreover, the removal efficiency of WWTP for Chemical oxygen Demand (COD),
Biological Oxygen Demand (BOD5), Total Suspended Solids (TSS), Total Nitrogen (T-N) and Total
Phosphorus (T-P) is higher than 96%, 99%, 98%, 86%, and 57%, respectively, and the final effluent
met the requirements of the Jordanian standards (JS893/2006). The wastewater characteristics and
performance of the WWTP were stable across sampling events with high BOD5/COD removal. The
plant treats a mixture of domestic, commercial, and industrial wastewater. In comparison with
regular and similar WWTPs in other regions of USA and Europe, the WWTP in Jordan receives a
higher concentration of pollutants in raw wastewater (up to 1247 mg/L of COD and up to 98 mg TN/L). This is might be caused by the low water consumption in Jordan (68 L/capita/day) as well as
the discharge of industrial wastewater in the catchment of As-Samra WWTP.
3.2. Occurrence of PPCPs in WWTP
The main pathway for the discharge of pharmaceuticals and personal care products (PPCPs)
into area waterways is through wastewater treatment plants (WWTPs), which are inefficient in
removing many compounds [7–11]. The results showed that 14 PPCPs were detected in the collected
samples from the influent and effluent of As-Samra WWTP (Table 3). These compounds are 1,7dimethylxanthine, amphetamine, acetaminophen, caffeine, carbamazepine, cimetidine, cotinine,
diphenhydramine, MDMA, morphine, phenazone, sulfamethazine, sulfamethoxazole,
thiabendazole, and trimethoprim. However, four PPCPs were below the detection limits (<0.005
µg/L), namely cimetidine, MDA, methamphetamine, and sulfachloropyridazine.
The PPCP compound with the highest estimated concentration was caffeine, followed by
acetaminophen and 1,7-dimethylxanthine. This is not surprising, since all three products are available
over the counter and used widely. Moreover, it is well documented in the literature that caffeine has
been detected in surface water worldwide, as it is widely used in a variety of food, beverages, and
drugs [22]. Caffeine had the highest concentration detected in the present study, with concentrations
ranging from 128.8 µg/L to 182.5 µg/L. This is consistent with some findings in the literature.
Actually, caffeine is a hydrophilic compound (log Kow = −0.07) and one the most widely detected
compounds in wastewater due to the high consumption of foods, beverages, and pharmaceuticals
containing this substance [23]. Moreover, Rodríguez-Gil et al. [24] reported that the highest caffeine
concentrations in WWTP influents and effluents are found in the Middle East region, with
concentrations almost 100 times higher than those estimated in Europe and Asia-Pacific, and 10 times
higher than those estimated in North America. Like caffeine, its primary metabolite (1,7dimetylxanthine or paraxanthine) had the third highest concentration detected in wastewater (10.49
µg/L). It is well known that 1,7-dimethylxanthine is generated from the human metabolite of caffeine,
which exists in many products (i.e., coffee, tea, chocolate, etc.).
Acetaminophen was the second highest compound detected in the raw wastewater (36.7 µg/L).
This could be due to the huge consumption of cough medicines and painkillers, which are also the
most abused medications. Actually, acetaminophen (paracetamol) is one of the most popular and
most commonly used analgesic and antipyretic drugs around the world, available without a
prescription. It was discovered over 100 years ago and has been widely used in medical practice for
more than half a century (since 1955). There are about 100 preparations in the market containing
paracetamol alone or in combination with other active substances [25].
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Table 3. Concentrations of pharmaceuticals and personal care products detected in collected grab
(ppb) from As-Samra WWTP.

PPCPs

1,7Dimethylxan
thine
Acetaminoph
en
Amphetamin
e
Caffeine
Carbamazepi
ne
Cimetidine
Cotinine
Diphenhydra
mine
MDA
MDMA
Methamphet
amine
Morphine
Phenazone
Sulfachlorop
yridazine
Sulfamethazi
ne
Sulfamethox
azole
Thiabendazo
le
Trimethopri
m

Influent
Concentration
(µg/L)
17 June
6 July
2017
2017

Average
Concentr
ation
(µg/L)

Effluent
Concentration (µg/L)
17 June
2017

6 July
2017

Average
Concentrat
ion (µg/L)

Efficienc
y
Removal

7.47

13.5

10.49

0.018

0.009

0.014

99.9

28.7

44.7

36.7

0.038

0.044

0.041

99.9

0.005

0.252

0.129

0.014

0.037

0.026

80.2

182.5

128.8

155.6

0.092

0.08

0.086

99.9

1.54

0.67

1.104

0.831

0.881

0.856

22.5

<0.005
4.67

<0.005
5.29

<0.005
4.98

<0.005
0.030

<0.005
0.125

<0.005
0.078

98.4

<0.005

<0.005

<0.005

0.061

0.026

0.044

–770.0

<0.005
0.018

<0.005
<0.005

<0.005
0.012

<0.005
<0.005

<0.005
<0.005

<0.005
<0.005

0.0
56.5

<0.005

<0.005

<0.005

<0.005

<0.005

<0.005

0.042
0.042

0.049
0.032

0.046
0.037

<0.005
0.017

<0.005
<0.005

<0.005
0.011

<0.005

<0.005

<0.005

<0.005

<0.005

<0.005

0.021

0.116

0.069

0.052

0.034

0.043

37.2

0.349

<0.005

0.177

0.161

0.031

0.096

45.8

0.012

0.017

0.015

0.013

0.021

0.017

−17.2

0.128

0.213

0.171

<0.005

<0.005

<0.005

97.1

89.0
70.3

% Removal = (influent − eﬄuent)/influent × 100.

3.3. Removal Efficiency of PPCPs in WWTP
The results showed that the levels of PPCPs in the wastewater effluent were lower than in the
raw influent, indicating that the majority of compounds can be at least partially removed by the
activated sludge system used at As-Samra WWTP. Table 3 shows that the removal efficiencies vary
greatly, with the lowest values (≤50%) for carbamazepine, sulfamethazine, sulfamethoxazole, and
thiabendazole, and the highest values (>98%) for 1,7-dimethylxanthine, acetaminophen, caffeine, and
cotinine. However, a moderate removal efficiency (70.3%) was shown for phenazone. Previous
studies have demonstrated that the removal efficiency for pharmaceutical ingredients can vary for
different wastewater treatment technologies and even for a given method [26,27]. Wastewater
treatments are usually divided into primary, secondary, and tertiary treatment systems [26]. The
treatment process at As-Samra is considered to be a secondary wastewater treatment system. The
removal efficiencies for PPCPs found in this plant were consistent with results reported for secondary
treatment systems worldwide [28,29]. However, to improve removal, a tertiary treatment system
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such as advanced oxidation can remove these compounds completely, but these methods are very
expensive to apply in big wastewater treatment plants [30].
The highest removal efficiencies of PPCPs were recorded for caffeine (99.9%), acetaminophen
(99.9%), 1,7-dimethylxanthine (99.9%), and cotinine (98.4%). The removal efficiency of these
compounds was very high (>98.4%) among the target compounds. It is well known that physical and
chemical properties of PPCPs play an important role in their transport and removal in the wastewater
treatment process. A plot of removal efficiency vs. Log of the octanol/water partition coefficient (Log
Kow) showed a relationship for most of the compounds (R-squared = ~0.71), with the removal
efficiency increasing as the Log Kow value decreased. For example, caffeine, 1,7-dimethylxanthine,
and acetaminophen were found to be the most hydrophilic (Log Kow < 1.0) and the most water soluble
(water solubility > 1000 mg/L) among the target compounds (Table 2). Therefore, due to the high
water solubility and low Log Kow, removal of these compounds by a sorption mechanism is unlikely
to occur [31]. Moreover, biodegradation is considered to be a major removal mechanism for these
hydrophilic compounds [32,33]. Batt et al. (2007) concluded that the removal of caffeine, among other
organic micropollutants in wastewater, is dependent on a combination of biological and
physicochemical treatment [34]. An efficient removal of caffeine, as that observed in the present
study, has also been reported using other biological treatment systems such as slow sand filters [35].
Moreover, the results clearly showed that two PPCPs (carbamazepine and thiabendazole) were
relatively unchanged after the treatment process at As-Samra WWTP. The water solubility of these
compounds is very low (17 mg/L and 50 mg/L, respectively) compared with other compounds.
Radjenovic et al. (2007) also reported poor biodegradability of carbamazepine in biological
wastewater treatment systems (e.g., active sludge systems) [36]. The low water solubility of these
compounds is believed to be an important factor of its resistance to treatment. Therefore, these
compounds are used as effluent tracer compounds in the environment. In addition, the removal
efficiency of thiabendazole had a negative value, which resulted from a higher concentration in the
effluent than in the influent of the WWTP. Many studies have reported a negative removal efficiency
for PPCPs that is caused by transformation, recombination, and/or accumulation of compounds
during secondary treatment [11,37,38]. Moreover, As-Samra Wastewater Treatment Plant (WWTP) is
the largest wastewater treatment facility in Jordan, which is located at Amman Zarqa Basin (AZB).
Its annual average discharge is about 118 × 106 m3 of treated wastewater, which runs in the Zarqa
river and is finally stored at King Talal Dam (KTD). A recent study showed that an analysis of the
same 18 PPCPs in surface water samples at KTD revealed the persistent presence of these compounds
in KTD water with the same distribution as in effluent samples from As-Samra WWTP [39]. This
study suggests that it is likely that WWTPs operating in AZB watersheds do not completely remove
PPCPs compounds, causing the transportation of these compounds to this important aquatic
ecosystem [39].
3.4. Comparison with Existing Studies
Among all PPCPs analyzed in the current study, acetaminophen, caffeine, cotinine, and
carbamazepine had the highest concentrations in the influent and effluent of As-Samra wastewater
treatment plants. These concentrations were also found to be comparable with concentrations
measured in domestic wastewater in India and USA (Figure 2a,b) [40,41], and higher than those
reported in Greece and Vietnam [42,43]. As for acetaminophen, it is one of the medicines sold all over
the world without the need for prescription. This is because of its mild effects on the human body
compared to other analgesic substances (e.g., diclofenac) and its high biodegradability in the
environment. Differently, caffeine is not a medicine but a stimulant that is widely consumed in
stimulant drinks such as coffee and soft drinks. The concentrations of PPCPs released by WWTPs
into the environment exhibit great variability, leading to inconclusive results [11]. This is mainly due
to the large number of variables involved in the behavior and transport of PPCPs from their sources
to the discharging point of WWTP, including fluctuations in consumption patterns, physicochemical
properties of these compounds, differing conditions in WWPT plants, influent concentration in
WWTPs, sewage composition, and plant operating parameters.
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(a) Influent

Concentration (ng/L)

100000

India

Greece

USA

Vietnam

As-Samra

10000

1000

100

10

1
Acetaminophen

Caffeine

Carbamazapine

Cotinine

100000

(b) Effluent

Concentration (ng/L)

10000

India

Greece

Vietnam

As-Samra

USA

1000

100

10

1
Acetaminophen

Caffeine

Carbamazepine

Cotinine

Figure 2. Concentrations of acetaminophen, caffeine, carbamazepine, and continine (ng/L) in Influent
(a) and Effluent (b) of wastewater treatment plants (India, Balakrishna et al. [40]; Greece,
Papageorgiou et al. [41], USA, Lubliner & Melanie [42]; Vietnam, Nguyen et al. [43]).

Removal efficiency rates of the PPCPs in As-Samra WWTP were generally consistent with those
of indicator compounds reported in the literature for conventional WWTPs. For instance, the removal
efficiency of carbamazepine observed in this study is comparable to those reported in WWTPs using
an activated sludge process [9]. Moreover, many studies have reported that carbamazepine is
recalcitrant in the environment and during wastewater treatment, which is mainly due to the lowest
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sorption and biodegradability in wastewater treatments [44,45]. Although data exists on the
occurrence and removal of PPCPs during WWTPs worldwide (Europe, USA, Canada, and Asia), to
the best of our knowledge, scarce data are currently available on the occurrence and removal of these
compounds in WWTPs located in the Middle East and North Africa (MENA region). Actually, the
research efforts made to address this issue in the MENA region is still lagging behind those in
developed countries due to lack of monitoring of PPCP compounds in water resources as well as lack
of availability of the analytical instruments and methods needed to identify PPCPs at low
concentration levels (ng/L).
4. Conclusions
Nine PPCPS were detected in the samples collected from the influent and effluent of As-Samra
WWTP, namely 1,7-dimethylxanthine, acetaminophen, caffeine, carbamazepine, cimetidine, cotinine,
phenazone, sulfamethazine, sulfamethoxazole, and thiabendazole. 1,7-Dimethylxanthine,
acetaminophen, and caffeine had the highest average concentrations in raw wastewater due to their
high over-the-counter availability and wide use. However, the highest average concentrations
detected in treated wastewater were for carbamazepine, sulfamethoxazole, caffeine, and cotinine.
This study clearly showed that incomplete removal and/or degradation of PPCPs takes place in AsSamra WWTP. Therefore, a monitoring campaign should be implemented to evaluate the occurrence
and removal of PPCPs in As-Samra WWTP over the four seasons. Moreover, there is a lot of scientific
research and information regarding the chemistry, toxicity, and fate of pharmaceutical contaminants
in wastewater treatment plants. Most of these research efforts have focused on removing these
contaminants from the effluent wastewater. However, less effort has been made to minimize the
levels of these contaminants at their sources, especially at home, pharmacies, and hospitals.
Therefore, there is a need in Jordan to raise public awareness about the impact of these contaminants
on water and the food cycle. This awareness will help the local authorities to implement any future
policies that cover pharmaceutical waste management and handling at home, pharmacies, and
hospitals.
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